pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 11·1 min read
save

DHL in talks with major pharma firms to manage sites amid ongoing trade disruptions

Jun 11, 2026·read at Endpoints ↗DealNeutral

DHL's healthcare logistics division is currently in discussions with several leading pharmaceutical manufacturers.

The drugmakers are exploring options for DHL to either assume control of their manufacturing or distribution sites, or to tap into DHL's logistics network and resources.

These talks reflect ongoing concerns about supply chain stability as trade disruptions continue to affect the industry, prompting pharma companies to seek more resilient logistics solutions.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec says”

read at Endpoints ↗
95 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING

related stories

  • May 8OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive
  • May 8Why we left the FDA: Six former officials share their storiesSTAT
  • May 8Opinion: We need more men in nursingSTAT
  • May 7Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papersSTAT
  • May 7Sarepta tumbles as its gene therapy sales decline furtherBioPharma Dive